Kock et al.r Oxypurines and allantoin in blood of patients with ischaemic diseascs 837 Eur. J. Clin. Chem. Clin. Biochem. Vol. 32, 1994, pp. 837-842 © 1994 (Received February 14/August 4, 1994) Summary: The aim of this study was the elucidation of the role of the xanthine oxidoreductase in the purine metabolism in ischaemic diseases of man. The serum concentrations of hypoxanthine, xanthine, uric acid and allantoin were determined in peripheral blood samples from patients with angina pectoris, cerebral insult and myocardial infarction with thrombolytic therapy and were compared with the concentrations obtained for healthy males and females. No significant differences were observed for the serum hypoxanthine concentrations, xanthine concentrations, the sum (hypoxanthine + xanthine) and the ratio (xanthine/hypoxanthine) between the healthy males, healthy females, the patients suffering from angina pectoris and the patients suffering from cerebral insult. An increase of the serum xanthine concentration in patients with myocardial infarction indicates a significant metabolic involvement of xanthine oxidoreductase in this disease and therefore a possible role in the development of tissue damage in the postischaemic phase due to oxygen radicals generated by the oxidase activity of this enzyme.
Introduction
xanthine, xanthine, uric acid and allantoin in samples from n = 115 patients with acute myocardial infarction Xanthine oxidoreductase (EC 1.2.3.2) is the terminal en-were compared with those in samples from n = 180 zyme of purine metabolism. Physiologically this enzyme hea , thy ma , eS5 n = M5 hea]thy females> n = 45 patients used NAD+ äs electron acceptor, but in ischaemia it with angina pectoris and n = 19 pat i e nts suffering from may be converted from the dehydrogehase form to an cerebra ] i n f ar ction. Furthermore the results of the serial oxidase form, which uses molecular oxygen äs an determinations of the serum concentrations of hypoxanelectron acceptor (1) . Several studies have been per-t^n^ xan thine, the sum (hypoxanthine + xanthine) and formed on the relevance of xanthine oxidase in tissue t h e ratio (xanthine/hypoxanthine) for n = 53 patients destruction by oxygen-derived radicals. De Scheerder w jth clinically diagnosed acute myocardial infarction concluded from the parallel coronary release of malon-were compared with classical clinical chemical markers dialdehyde and uric acid, that there is an enhanced un-for the diagnosis and follow-up of this disease. The specific oxidation of membrane phospholipids by oxy-method used for the simultaneous determination of hygen-derived radicals produced by xanthine oxidase (2) . poxanthine, xanthine, uric acid and allantoin from serum In the present study the serum concentrations of hypo-was presented in a previous publication (3). toris and patients suffering from cerebral insult versus patients with acute myocardial infarction.
Materials and Methods

Chemicals
Munichi Germany) were used. rie acid was Standard Reference Material with a.purity of 99.7% (SRM 913, National Bureau of Standards, Washington D. C. 20234). The reagents required f r the For the preparation of Standard Solutions of allantoin, hyppxanthine" determinatioii of the enzyme acti vities of creatine kinase and creand xanthine, materials of the highest available purity (SIGMA, atine kinase isoenzyme MB wejrp from Boehringer Mannheim.
All other Chemicals were purchased from Merck (Darmstadt, Germany) and were of analytical grade; methanol was of HPLC-grade.
Samples
For the drawing blood the Sarstedt-system with separation-gel was used and the time between blood withdrawal and centrifugation never exceeded 30 min.
The samples in this study were from 180 healthy adult males, 145 healthy adult females, 155 adult patients with acute myocardial infarction and successful thrombolytic therapy according to clinical observations, 45 patients suffering from angina pectoris, and 19 patients with a cerebral infarction. The patient samples were drawn within 3-7 h after hospitalization.
All the samples taken from 53 patients with acute myocardial infarction for diagnostic purposes and follow-up were analysed. These patients showed early reperfusion of the occluded coronary artery spontaneously or s a result of therapeutic lysis.
High performance liquid chromatography HPLC was performed on a Waters chromatography System with a gradient pump Model 600, a Satellite WISP Model 700 and a tuneable wavelength detector Model 481. System control, data acquisition, Integration and calibration were performed with the Waters Maxima 825 Software. Chromatographie separations were performed s described in 1. c. (3) . For the determination of hypoxanthine, xanthine and uric acid, UV-detection was performed at 254 nm with a r nge of 0.005 absorbance units f ll scale and a time constant of l .0 s. For the determination of allantoin s described in 1. c. (3), UV-detection was performed at 360 nm with a r nge of 0.100 absorbance units f ll scale and a time constant of 1.0 s.
The method used in this study had a detection limit for hypoxanthine of l pmol and for xanthine of l .5 pmol; since 50 μΐ of fivefold diluted serum were injected, the lower concentration limit for hypoxanthine and xanthine was 0.1 μηηοΐ/ΐ and 0.15 μπιοΐ/ΐ, respectively. For serum hypoxanthine concentrations of 5-50 μιτιοΐ/ΐ the coefficient of Variation did not exceed 5%; for xanthine concentrations of 2-20 μιτιοΐ/ΐ the imprecision was less than 7%.
Determination of enzyme activities
The determination of the enzyme activities of creatine kinase and creatine kinase-MB were performed on a Hitachi 747 at 25 °C with the reagent kits obtained from Boehringer Mannheim.
Statistical procedures and calculations
For data management, Microsoft Excel 3.0a (Microsoft GmbH, Munich, Germany) was used. Statistical treatments, including the calculation of the Bayesian parameters for the sample classification, were performed with the Statistical package Sigmastat V 1.02 (Jandel Scientific GmbH, Erkrath, Germany).
Results
Hypoxanthine and xanthine from single serum samples
In figure l a-b the distribution of the hypoxanthine and xanthine concentrations in sera from patients with myoTab. l Results for the determination of hypoxanthine, xanthine, the sum (hypoxanthine + xanthine) and the ratio (xanthine/hypoxanthine). The samples from the patients were drawn at the intensive care unit within 3-7 h after hospitalization. cardial infarction are shown versus those obtained for healthy males, healthy females, patients with angina pectoris and patients with cerebral insult. Table l shows the statistical quantities of the distributions, and the statistical quantities of the distribution of the sum (hypoxanthine + xanthine), the ratio (xanthine/hypoxanthine), total creatine kinase activity and creatine kinase-MB activity. 7he data of the n = 45 patients suffering from angina pectoris and of the n = 19 patients suffering from cerebral insult cannot be discriminated from the data obtained for healthy males and healthy females. Sensitivity and specificity of the studied analytes were calculated from the results obtained for the samples from n = 155 patients suffering from myocardial infarction and the results for the n = 389 samples combined from the four groups of healthy males, healthy females, angina pectoris and cerebral insult. Hypoxanthine showed a sensitivity of 0.59 for a specificity of 0.90 at a discriminator value of 14.7 μπιοΐ/ΐ, xanthine a sensitivity of 0.83 for a specificity of 0.90 at a discriminator value of 4.5 μηηο1/1, the sum (hypoxanthine + xanthine) a sensitivity of 0.77 for a specificity of 0.90 at a discriminator value of 19.7 μιτιοΐ/ΐ, and the ratio (xanthine/hypoxanthine) a sensitivity of 0.35 for a specificity of 0.90 at a discriminator value of 0.78. The ROC-curves are shown in figure 2.
Tab. 2 Results for the determination of uric acid and allantoin. The samples are the same s in table 1. Uric acid and allantoin from single serum samples Table 2 summarizes the data for the determination of uric acid and allantoin from the samples used for the data in figure l a-b. The distribution of the serum concentrations of uric acid and the distribution of serum concentrations of allantoin in the samples from patients with myocardial infarction was not significantly different from the distribution in the samples of the reference c llectives.
Release profiles of purines and total creatine kinase/kreatine kinase-MB derived from sera of patients with myocardial infarction Figure 3a -b shows the data for hypoxanthine, xanthine, total creatine kinase and creatine kinase-MB from serial serum samples, obtained from n = 53 patients with myocardial infarction, hospitalized at the cardiological intensive care unit between 5 h and 150 h after pain onset. For the samples drawn initially (= 5 ± 2 h after pain onset), only the median for the serum xanthine coneentration exceeded the discriminator value for a specificity of 0.90. For hypoxanthine in median of the meas fed serum concentration feil below the discriminator value for a speeificity of 0.9 after 80-100 h. For xanthine, the median of the measured serum concentration< feil below the discriminator value for a specificity of 0.9 after 100-l25 h. After 125h the median of the total creatine kinase serum activity feil below the upper limit of the reference ränge used for this method in our laboratory.
Cpnclusions
This clinical study of purine rrietabolism, following myocardial ischaemia fesulting frprn myocardial infarction, was perfbrmed in order to elucidate the possible role of xanthine oxidoreductase iri tissüe alterations in the post-ischaemic phäse. During ischaemia there is a calcium-dependent enzymatic degradation of xanthine oxidoreductase frorn the NAD + -consurning dehydrogenase form to an oxidase form, which directly utilizes moleculär oxygen äs an electron acceptor in the oxidation of hypoxanthine via xanthine to uric acid (1,4^5) . This enzyme could yield very reactive, oxygen-derived radical ions, which could, if not scavenged by appropriate radical-scavengers, lead to fiirther tissüe destruction (6) .
To assess the detectability of changes of purine metabolism in myocardial tissüe, using peripheral serum samples, the results for serum hypoxanthine, xanthine, the sum (hypoxanthine -K xanthine) and the ratio (xanthine/ hypoxanthine) were determined in blood samples of n = 155 patients suffering from myocardial infarction versus appropriate reference collectives. The data shown in figure l a-b and summarized in table l indicate an increased efflux of hypoxanthine and xanthine from the injured tissüe similar to the efflux of creatine kinase. The sensitivity and specificity data calculated from the distributions of purine serum concentrations show that the elevation of the serum xanthine concentration is most specific for the patients with myocardial infarction. The determination of hypoxanthine is much more unspecific; this analyte is subject to preanalytical errors (7), but cell death and damage might also be responsible for an increase of the hypoxanthine serum concentration.
The derived quantities, the sum (hypoxanthine + xanthine) and the ratio (xanthine/hypoxanthine) are less informative about disease-specific metabolic changes, but the unequivocal increase of serum xanthine must be due to xanthine oxidoreductase activity directly connected with the metabolic changes of myocardial ischaemia. Consequently, the values for xanthine in the samples drawn between approximately 5 hours and 6 days after pain onset (from the patients kept ander surveillance after initial hospitalization in the cardiological intensive care unit) show an elevation above a discriminator value required for a specificity of 0.90 for the longest time after pain onset.
The main result of this study is that the xanthine concen* tration measured in serum derived from peripheral blood is significantly increased in samples of patients suffering from myocardial infarction, compared with sera of an appropriate reference collective. The metabolic activity of xanthine oxidoreductase in myocardial infarction has therefore been proven in this study, and the fact that the release of xanthine persists for four to five days after pain onset on a level above the normal ränge, Supports the role of xanthine oxidoreductase, which has been previously and controversially suggested (9) (10) (11) (12) (13) (14) .
On the other hand, the existence of oxygen-derived radicals was not supported by examination of a radical-scavenging mechanism, the spontaneous oxidation of uric << acid to allantoin. Grootveld (8) has shown that allantoin ' . ; is the best marker for the detection of oxygen-radical ; · induced spontaneous oxidation of uric acid and therefore the best index for the activity of uric acid äs a radicalscavenger. Table 2 shows that there is no difference between the groups (see tab. 1) with respect to uric acid or allantoin. But the absence of a response by allantoin only hidicates that the oxygen^radicals, if generated, are preferably subject to other radical-scavenging mechanismSj in contrast to the diseases described by Grootveld (8) .
Therefore, the clinical relevance of the findings in this · study depends on the validity of those resülts that indi-' "' cate that the oxygen-consuming O-form of the xanthine oxidoreductase is the predöminant form in the later phase of myocardial infarction (15) .
For elimination of the remaining ambiguities of the preŝ ent resülts, additional studies must be performed to clarify qf the origin, the kinetics and the fate of the xanthine oxidoreductase involved in the metabolic changes following myocardial infarction. Additionally, the origin of the purine metabolites that lead tö the long-term elevation of the xanthine effusion from the heart must be elücidated.
